Short- and long-term outcomes of AL amyloidosis patients admitted into intensive care units.

about

Short- and long-term outcomes of AL amyloidosis patients admitted into intensive care units.

Item

http://www.wikidata.org/entity/Q40705462

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Short- and long-term outcomes ...... ted into intensive care units.

@en

type

Item

label

Short- and long-term outcomes ...... ted into intensive care units.

@en

prefLabel

Short- and long-term outcomes ...... ted into intensive care units.

@en

P1476

Short- and long-term outcomes ...... tted into intensive care units

@en

P2093

Antoine Huart

http://www.w3.org/2001/XMLSchema#string

Bertrand Arnulf

http://www.w3.org/2001/XMLSchema#string

Claire Pichereau

http://www.w3.org/2001/XMLSchema#string

Damien Guinault

http://www.w3.org/2001/XMLSchema#string

David Ribes

http://www.w3.org/2001/XMLSchema#string

Dominique Chauveau

http://www.w3.org/2001/XMLSchema#string

Elie Azoulay

http://www.w3.org/2001/XMLSchema#string

Emmanuel Canet

http://www.w3.org/2001/XMLSchema#string

Laurence Lavayssiere

http://www.w3.org/2001/XMLSchema#string

Marie-Béatrice Nogier

http://www.w3.org/2001/XMLSchema#string

P2860

Incidence and risk of cardiotoxicity associated with bortezomib in the treatment of cancer: a systematic review and meta-analysis

Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004.

Immunoglobulin light chain amyloidosis: 2014 update on diagnosis, prognosis, and treatment.

Diagnosis and management of the cardiac amyloidoses.

Natural history and outcome in systemic AA amyloidosis.

Outcomes of critically ill patients with hematologic malignancies: prospective multicenter data from France and Belgium--a groupe de recherche respiratoire en réanimation onco-hématologique study.

Systemic amyloidosis in England: an epidemiological study

Molecular mechanisms of amyloidosis.

Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naïve patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III).

Outcomes and prognostic factors in patients with haematological malignancy admitted to a specialist cancer intensive care unit: a 5 yr study.

P304

868-875

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BJH.14135

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

174

http://www.w3.org/2001/XMLSchema#string

P50

Arnaud Jaccard

Murielle Roussel

Michel Attal

P577

2016-06-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27292694

http://www.w3.org/2001/XMLSchema#string

P921

intensive care unit